Viridian Therapeutics Ors Inc (VRDN)
R&D Expenses
$324.68M
TTM · Period ending: · USD
VRDN R&D Expenses
Latest reported$324.68Mperiod ending
Latest reported$324.68Mperiod ending
VRDN R&D Expenses ($225.38K → $324.68M)
Annual R&D Expenses
High-resolution chart · PNG
VRDN r&d expenses history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expenses (USD) |
|---|---|
| 338,929,000 | |
| 238,254,000 | |
| 159,765,000 | |
| 100,894,000 | |
| 56,886,000 | |
| 28,304,000 | |
| 34,794,000 | |
| 30,421,000 | |
| 19,623,000 | |
| 888,000 | |
| 1,002,000 | |
| 293,000 | |
| 96,847 | |
| 225,378 |